Related references
Note: Only part of the references are listed.Impact of Renin-angiotensin System Inhibitors on the Efficacy of Anti-PD-1/PD-L1 Antibodies in NSCLC Patients
Takehiro Tozuka et al.
ANTICANCER RESEARCH (2021)
Angiotensin Blockade Modulates the Activity of PD1/L1 Inhibitors in Metastatic Urothelial Carcinoma
Rohit K. Jain et al.
CLINICAL GENITOURINARY CANCER (2021)
Turning cold tumors into hot tumors by improving T-cell infiltration
Yuan-Tong Liu et al.
THERANOSTICS (2021)
2020 International Society of Hypertension Global Hypertension Practice Guidelines
Thomas Unger et al.
HYPERTENSION (2020)
A decade of immune-checkpoint inhibitors in cancer therapy
Caroline Robert
NATURE COMMUNICATIONS (2020)
Reprogramming the microenvironment with tumor-selective angiotensin blockers enhances cancer immunotherapy
Vikash P. Chauhan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanced Pancreatic Cancer A Phase 2 Clinical Trial
Janet E. Murphy et al.
JAMA ONCOLOGY (2019)
Immune-Related Adverse Events: A Case-Based Approach
Caoilfhionn Connolly et al.
FRONTIERS IN ONCOLOGY (2019)
Losartan treatment enhances chemotherapy efficacy and reduces ascites in ovarian cancer models by normalizing the tumor stroma
Yanxia Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Renin-Angiotensin System Inhibitors to Mitigate Cancer Treatment-Related Adverse Events
Matthias Pinter et al.
CLINICAL CANCER RESEARCH (2018)
Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges
Dal Fukurnura et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
Alexander M. M. Eggermont et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Cancer immunotherapy using checkpoint blockade
Antoni Ribas et al.
SCIENCE (2018)
Effect of angiotensin system inhibitors on survival in newly diagnosed glioma patients and recurrent glioblastoma patients receiving chemotherapy and/or bevacizumab
Victor A. Levin et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
Targeting the renin-angiotensin system to improve cancer treatment: Implications for immunotherapy
Matthias Pinter et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Use of inhibitors of the renin-angiotensin system is associated with longer survival in patients with hepatocellular carcinoma
Matthias Pinter et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2017)
Use of Angiotensin System Inhibitors Is Associated with Immune Activation and Longer Survival in Nonmetastatic Pancreatic Ductal Adenocarcinoma
Hao Liu et al.
CLINICAL CANCER RESEARCH (2017)
Effect of Angiotensin System Inhibitors on Survival in Patients Receiving Chemotherapy for Advanced Non-Small-Cell Lung Cancer
Alex R. Menter et al.
CLINICAL LUNG CANCER (2017)
Hypertension and angiotensin system inhibitors: impact on outcome in sunitinib-treated patients for metastatic renal cell carcinoma
H. Izzedine et al.
ANNALS OF ONCOLOGY (2015)
Angiotensin System Inhibitors and Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma
Rana R. McKay et al.
CLINICAL CANCER RESEARCH (2015)
Angiotensin II type-1 receptor blockers enhance the effects of bevacizumab-based chemotherapy in metastatic colorectal cancer patients
Hiroki Osumi et al.
MOLECULAR AND CLINICAL ONCOLOGY (2015)
Angiotensin II Drives the Production of Tumor-Promoting Macrophages
Virna Cortez-Retamozo et al.
IMMUNITY (2013)
Oncology Meets Immunology: The Cancer-Immunity Cycle
Daniel S. Chen et al.
IMMUNITY (2013)
Normalizing Tumor Microenvironment to Treat Cancer: Bench to Bedside to Biomarkers
Rakesh K. Jain
JOURNAL OF CLINICAL ONCOLOGY (2013)
Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels
Vikash P. Chauhan et al.
NATURE COMMUNICATIONS (2013)
Angiotensin system inhibitors and outcome of sunitinib treatment in patients with metastatic renal cell carcinoma: A retrospective examination
Daniel Keizman et al.
EUROPEAN JOURNAL OF CANCER (2011)
The renin-angiotensin system and cancer: old dog, new tricks
Amee J. George et al.
NATURE REVIEWS CANCER (2010)
Share Paper
